Review Article: Contemporary Transcatheter Heart Valves for TAVI in Bicuspid Aortic Anatomy
- PMID: 40283668
- PMCID: PMC12027816
- DOI: 10.3390/jcm14082838
Review Article: Contemporary Transcatheter Heart Valves for TAVI in Bicuspid Aortic Anatomy
Abstract
Bicuspid aortic valve (BAV) is the most common congenital heart disease, affecting 0.5-2% of the population and often leading to early aortic valve degeneration. While surgical aortic valve replacement (SAVR) remains the gold standard for treating severe bicuspid aortic stenosis (AS), transcatheter aortic valve implantation (TAVI) is emerging as a viable alternative in selected BAV anatomies. Initial experiences with first-generation transcatheter heart valves (THVs) showed the feasibility of this technique, but were associated with lower device success rates and higher complications, such as paravalvular leak (PVL) and pacemaker implantation. Advancements in second- and third- generation THVs, together with better pre-procedural imaging assessment and growing operator experience, have significantly enhanced TAVI outcomes in BAV patients, with results now comparable to those seen in tricuspid aortic valves (TAVs). Proper patient selection, pre-procedural sizing, and device implantation are key to improving TAVI success in BAV. Recent registry data on contemporary THV platforms demonstrate improved procedural success, hemodynamic performance, and the safety of TAVI in BAV. However, higher rates of PVL, pacemaker implantation, and strokes remain concerns. Ongoing advancements in THV design and procedural techniques will further enhance outcomes for this challenging population. Up to the present, there are no dedicated THVs for BAV, but the latest-generation THVs offer promising results.
Keywords: balloon-expandable valve (BEV); bicuspid aortic valve (BAV); paravalvular leak (PVL); permanent pacemaker implantation (PPI); self-expanding valve (SEV); transcatheter aortic valve implantation (TAVI).
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
Transcatheter Aortic Valve Implantation for Severe Bicuspid Aortic Stenosis - 2 Years Follow up Experience From India.Front Cardiovasc Med. 2022 Jul 28;9:817705. doi: 10.3389/fcvm.2022.817705. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35966565 Free PMC article.
-
Patients With Bicuspid Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.Front Cardiovasc Med. 2022 Mar 16;9:794850. doi: 10.3389/fcvm.2022.794850. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35369357 Free PMC article.
-
Transcatheter Aortic Valve Implantation (TAVI) in Bicuspid Anatomy.J Clin Med. 2025 Jan 24;14(3):772. doi: 10.3390/jcm14030772. J Clin Med. 2025. PMID: 39941442 Free PMC article. Review.
-
Three-year clinical outcomes after transcatheter aortic valve implantation in patients with bicuspid aortic disease: Comparison between self-expanding and balloon-expandable valves.Catheter Cardiovasc Interv. 2024 May;103(6):1004-1014. doi: 10.1002/ccd.31041. Epub 2024 Apr 5. Catheter Cardiovasc Interv. 2024. PMID: 38577939
-
Safety and efficacy of minimalist transcatheter aortic valve implantation using a new-generation balloon-expandable transcatheter heart valve in bicuspid and tricuspid aortic valves.Clin Res Cardiol. 2021 Dec;110(12):1993-2006. doi: 10.1007/s00392-021-01935-7. Epub 2021 Sep 9. Clin Res Cardiol. 2021. PMID: 34505192
References
-
- Michelena H.I., Prakash S.K., Della Corte A., Bissell M.M., Anavekar N., Mathieu P., Bossé Y., Limongelli G., Bossone E., Benson D.W., et al. Bicuspid aortic valve: Identifying knowledge gaps and rising to the challenge from the International Bicuspid Aortic Valve Consortium (BAVCon) Circulation. 2014;129:2691–2704. doi: 10.1161/CIRCULATIONAHA.113.007851. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials